Navigation Links
Alzheimer's Disease Caused By Insulin Increase

Mark A. Fishel, M.D., from the University of Washington, Seattle, and colleagues, have investigated the role of insulin increase in Alzheimer’s disease. Moderately elevated levels of insulin increase the levels of inflammatory markers and beta-amyloid // in plasma and in cerebrospinal fluid and these markers may contribute to Alzheimer's disease

The test was conducted in 16 healthy older adults ranging in age from 55 to 81 years, the investigators raised blood insulin levels (while maintaining normal blood sugar levels) and then and then measured the changes in levels of inflammatory markers, modulators, and beta-amyloid (a protein associated with AD) in plasma and cerebrospinal fluid.

"Moderate peripheral hyperinsulinaemia (increased levels of insulin) provoked striking increases in CNS (central nervous system) inflammatory markers," the authors report. "Our findings suggest that insulin-resistant conditions such as diabetes mellitus and hypertension may increase the risk for AD, in part through insulin-induced inflammation."

"Although this model has obvious relevance for diabetes mellitus, hyperinsulinaemia and insulin resistance are widespread conditions that affect many non-diabetic adults with obesity, impaired glucose tolerance, cardiovascular disease, and hypertension. Our results provide a cautionary note for the current epidemic of such conditions, which, in the context of an aging population, may provoke a dramatic increase in the prevalence of AD. More encouragingly, greater understanding of insulin's role in AD pathogenesis may lead to novel and more effective strategies for treating, delaying, or even preventing this challenging disease," the authors conclude.

Source: Archives of Neurology, JAM
'"/>




Page: 1

Related medicine news :

1. Evidence Links Protein Damage to Neurodegenerative diseases like Parkinsons and Alzheimers
2. Decrease in testosterone levels lead to Alzheimers
3. Smokers are prone to Alzheimers
4. Over-The-Counter Drugs May Prevent Alzheimers
5. Alzheimers followed by head injury
6. Vitamin E useful for Alzheimers
7. Staying mentally energitic prevents Alzheimers
8. Researchers trick Alzheimers Enzyme
9. Drug Offers Hope for Alzheimers disease
10. Alzheimers with psychosis runs in families
11. Blood test may aid foretell Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/25/2017)... ... September 25, 2017 , ... SyncDog, Inc., ... of SentinelSecure™, version 3.0, will be available in a managed cloud services model, ... SentinelSecure™ comes with several new enhancements including support for caller ID and network ...
(Date:9/25/2017)... ... 2017 , ... Nissar A. Darmani, PhD, has been awarded a record WesternU ... nausea and vomiting. Dr. Darmani is Associate Dean of Basic Medical Sciences in ... is from the National Cancer Institute (NCI) arm of the National Institutes of Health ...
(Date:9/25/2017)... ... September 25, 2017 , ... Just ask anyone old enough to remember what ... headgear so wired up and containing so much metal that jokes about radio reception ... its treatments can barely be observed. As a result, it’s now a billion-dollar industry ...
(Date:9/25/2017)... ... September 25, 2017 , ... Winners in ... announced on Friday, September 22 during a gala event in New York City. ... achievements and HR-related products and suppliers who help to create and drive great ...
(Date:9/25/2017)... ... September 25, 2017 , ... How many things are on your average daily ... “more than any sane human could possibly complete,” then you’re all too familiar with ... desperately trying to be everything to everybody all the time. , Self-proclaimed overly productive ...
Breaking Medicine News(10 mins):
(Date:9/7/2017)... BOTHELL, Wash. , Sept. 7, 2017   BioLife ... developer, manufacturer and marketer of proprietary clinical grade cell and ... media ("BioLife"), announces that Mike Rice , President and ... Rodman & Renshaw 19 th ... 3:25 p.m. Eastern time (12:25 p.m. Pacific time). The conference ...
(Date:9/6/2017)... -- Eli Lilly and Company (NYSE: LLY ... galcanezumab and lasmiditan, two investigational treatments for migraine, at ... taking place Sept. 7-10 in Vancouver ... data from an open-label study evaluating the safety and ... 240 mg) for the prevention of migraine. Galcanezumab is ...
(Date:9/5/2017)... , Sept. 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... has successfully concluded its meeting with the U.S. Food ... oral insulin formulation. ... the regulatory pathway for submission of ORMD-0801, would be ...
Breaking Medicine Technology: